Paediatrics Search
Paediatrics Paediatrics
mumps
MUMPS
Mumps is a self-limited viral disease characterized by nonsuppurative swelling and tenderness of one or both parotid glands.
It commonly affects the children aged 2-12 years and very uncommon in <1 year of age.
It is caused by a single-stranded RNA virus classified under Paramyxoviridae family or mumps virus.
Transmission is through airborne droplets from respiratory secretion of infected persons.
Incubation period is typically 14-21 days.

Prevention

Mumps Vaccine

  • Available as a single-antigen preparation or combined w/ other vaccines [eg mumps & rubella (MMR), or also w/ varicella (MMRV)]
    • Single-antigen is not routinely recommended
    • Based on several studies, a single dose of MMR is 75-91% effective while vaccine effectiveness of 88% is seen w/ 2 doses
    • MMRV is approved for use in healthy children 1-12 yrs of age
  • Single-antigen (MMR) is indicated for children ≥1 yr of age w/ low risk for mumps exposure
  • Second-dose MMR is indicated for children 4-6 yr of age at high risk for mumps exposure
  • Second dose should be given >1 mth after the 1st dose
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Vaping tied to sexual, substance-related risk behaviours in teens
Audrey Abella, 07 May 2019
Use of electronic vapour products (EVP), or vaping, has been associated with an increased likelihood of engaging in sexual and substance-use risk behaviours among US teenagers, according to data from the 2017 National Youth Risk Behaviour Survey presented at the Paediatric Academic Societies (PAS) 2019 Meeting.